Freitag Gregory Gene

Freitag Gregory Gene is listed in filings as Director at PDS Biotechnology Corporation. This profile follows SEC Form 4 activity through Mar 3, 2026, including purchase activity. Recent filings connect the profile to PDS Biotechnology Corporation (PDSB) and ZyVersa Therapeutics, Inc. (ZVSA). The current snapshot covers public activity from Jun 25, 2024 to Mar 3, 2026. Reported amounts are shown as $53.8K to $39.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.